探索斑秃与重性抑郁障碍的重叠:流行病学与遗传学视角
重性抑郁障碍多基因风险评分仅解释斑秃病例对照状态方差的1%,且信号局限于6号染色体MHC区域,排除MHC后LDSC回归未发现显著遗传相关。
要点
- 人群队列中24%的斑秃患者共病重性抑郁障碍,临床样本中为44%。
- 重性抑郁障碍多基因风险评分仅解释斑秃病例对照状态方差的1%。
- 该遗传信号局限于6号染色体MHC区域,排除MHC后未发现显著遗传相关。
核心结论
- 斑秃患者的重性抑郁障碍患病率升高,与既往研究一致。
- 遗传重叠可能仅限于与免疫功能相关的MHC区域。
- 需要更详细的研究来细化对MHC如何参与斑秃与重性抑郁障碍共病发展的理解。
研究设计与样本
- 流行病学分析使用德国成人健康保险受益人队列(n=1.855百万)确定斑秃-重性抑郁障碍共病的群体患病率。
- 在具有精神病学表型数据的临床斑秃病例对照样本中分析重性抑郁障碍患病率,并按人口学因素分层。
- 采用多基因风险评分(PRS)方法研究斑秃与重性抑郁障碍的遗传重叠,以重性抑郁障碍GWAS荟萃分析(PGC-MD2)汇总统计为训练样本,以中欧斑秃队列(含上述斑秃患者)和独立的美国斑秃复制队列为目标样本。
- 采用连锁不平衡得分(LDSC)回归,使用PGC-MD2和迄今最大斑秃荟萃分析的汇总统计。
主要发现
- 人群样本中斑秃患者的重性抑郁障碍患病率为24%。
- 临床样本中斑秃患者的重性抑郁障碍患病率为44%。
- 重性抑郁障碍PRS解释斑秃病例对照状态方差的R²=1%。
- 该信号局限于6号染色体MHC区域。
- LDSC回归(排除MHC)未发现斑秃与重性抑郁障碍之间存在显著遗传相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更详细的研究来细化对MHC如何参与斑秃与重性抑郁障碍共病发展的理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Research suggests that Alopecia areata (AA) and Major Depressive Disorder (MDD) show substantial comorbidity. To date, no study has investigated the hypothesis that this is attributable to shared genetic aetiology. OBJECTIVES: To investigate AA-MDD comorbidity on the epidemiological and molecular genetic levels. METHODS: First, epidemiological analyses were performed using data from a cohort of adult German health insurance beneficiaries (n = 1.855 million) to determine the population-based prevalence of AA-MDD comorbidity. Second, analyses were performed to determine the prevalence of MDD in a clinical AA case-control sample with data on psychiatric phenotypes, stratifying for demographic factors to identify possible contributing factors to AA-MDD comorbidity. Third, the genetic overlap between AA and MDD was investigated using a polygenic risk score (PRS) approach and linkage disequilibrium score (LDSC) regression. For PRS, summary statistics from a large MDD GWAS meta-analysis (PGC-MD2) were used as the training sample, while a Central European AA cohort, including the above-mentioned AA patients, and an independent replication US-AA cohort were used as target samples. LDSC was performed using summary statistics of PGC-MD2 and the largest AA meta-analysis to date. RESULTS: High levels of AA-MDD comorbidity were reported in the population-based (MDD in 24% of AA patients), and clinical samples (MDD in 44% of AA patients). MDD-PRS explained a modest proportion of variance in AA case-control status (R2 = 1%). This signal was limited to the major histocompatibility complex (MHC) region on chromosome 6. LDSC regression (excluding MHC) revealed no significant genetic correlation between AA and MDD. CONCLUSIONS: As in previous research, AA patients showed an increased prevalence of MDD. The present analyses suggest that genetic overlap may be confined to the MHC region, which is implicated in immune function. More detailed investigation is required to refine understanding of how the MHC is involved in the development of AA and MDD comorbidity.
引用
- Foo JC, Redler S, Forstner AJ, et al. Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives. J Eur Acad Dermatol Venereol. 2023. PMID: 36695075. doi:10.1111/jdv.18921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。